Severe cutaneous adverse reactions: Emergency approach to non-burn epidermolytic syndromes

Intensive Care Medicine

Volumn 36, Issue 1, 2010, Pages 22-32

  Struck, Manuel Florian ^a   Hilbert, Peter ^a   Mockenhaupt, Maja ^b   Reichelt, Beate ^a   Steen, Michael ^a  

^a BG KLINIKEN BERGMANNSTROST   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Burn center; Critical care; Emergency medical service; Patient transfer; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BIOBRANE; CATECHOLAMINE; CHLORHEXIDINE; COTRIMOXAZOLE; IMMUNOGLOBULIN; INOTROPIC AGENT; KETAMINE; LAMOTRIGINE; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTENIDINE; OPIATE; OXICAM DERIVATIVE; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; SILVER NITRATE; STEROID; SULFONAMIDE; VASOPRESSIN;

ARTIFICIAL VENTILATION; BLEEDING; BURN; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGICAL DATA; EPIDERMOLYSIS; FLUID THERAPY; GENETIC ANALYSIS; HISTOLOGY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LOW DRUG DOSE; MORTALITY; OXYGEN THERAPY; PATHOGENESIS; PATIENT TRANSPORT; RESUSCITATION; REVIEW; RISK FACTOR; SEVERE CUTANEOUS ADVERSE REACTION; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; WOUND CARE; WOUND DRESSING; WOUND HEALING;

COATED MATERIALS, BIOCOMPATIBLE; DIAGNOSIS, DIFFERENTIAL; EMERGENCY MEDICAL SERVICES; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; IMMUNOLOGIC FACTORS; INTENSIVE CARE; SEVERITY OF ILLNESS INDEX; STEVENS-JOHNSON SYNDROME; WOUND HEALING;

EID: 76549097085     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1659-1     Document Type: Review

References (81)

1. M Spies PM Vogt DN Herndon 2003 Toxic epidermal necrolysis. A case for the burn intensive care unit Chirurg 74 452 460 10.1007/s00104-002-0571-9 12748794 (Pubitemid 38270181)
2. S Bastuji-Garin B Rzany RS Stern NH Shear L Naldi JC Roujeau 1993 Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 129 92 96 10.1001/archderm.129. 1.92 8420497 (Pubitemid 23029676)
3. KA Arndt 1970 The sign of Pyotr Vasilyewich Nikolsky N Engl J Med 282 1154 1155 5439414
4. H Assier S Bastuji-Garin J Revuz JC Roujeau 1995 Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes Arch Dermatol 131 539 543 10.1001/archderm.131.5.539 7741539
5. B Rzany O Hering M Mockenhaupt W Schröder E Goerttler J Ring E Schöpf 1996 Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis Br J Dermatol 135 6 11 10.1111/j.1365-2133.1996. tb03598.x 8776350 (Pubitemid 26225106)
6. A Lyell 1956 Toxic epidermal necrolysis: an eruption resembling scalding of the skin Br J Dermatol 68 355 361 10.1111/j.1365-2133.1956.tb12766.x 13374196
7. K Iwatsuki O Yamasaki S Morizane T Oono 2006 Staphylococcal cutaneous infections: invasion, evasion and aggression J Dermatol Sci 42 203 214 10.1016/j.jdermsci.2006.03.011 16679003
8. DF Mutasim 2003 Autoimmune bullous dermatoses in the elderly: diagnosis and management Drugs Aging 20 663 681 10.2165/00002512-200320090-00004 12831291 (Pubitemid 36920511)
9. M Mockenhaupt J Norgauer 2002 Cutaneous adverse drug reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis Allergy Clin Immunol Int 14 143 150 10.1027/0838-1925.14.4.143
10. B Rzany M Mockenhaupt S Baur W Schröder U Stocker J Mueller N Holländer R Bruppacher E Schöpf 1996 Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson Syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry J Clin Epidemiol 49 769 777 10.1016/0895-4356(96)00035-2 8691227 (Pubitemid 26280728)
11. M Mockenhaupt M Idzko M Grosber E Schöpf J Norgauer 2005 Epidemiology of staphylococcal scalded skin syndrome in Germany J Invest Dermatol 125 700 703 10.1111/j.0022-202X.2005.23642.x (Pubitemid 40489495)
12. S Bastuji-Garin N Fouchard M Bertocchi JC Roujeau J Revuz P Wolkenstein 2000 SCORTEN: a severity-of-illness score for toxic epidermal necrolysis J Invest Dermatol 115 149 153 10.1046/j.1523-1747.2000.00061.x 10951229 (Pubitemid 30637181)
13. AH Dorafshar SR Dickie AB Cohn JK Aycock A O'Connor A Tung LJ Gottlieb 2008 Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach Plast Reconstr Surg 122 154 160 10.1097/PRS.0b013e3181773d5d 18594400
14. S Guegan S Bastuji-Garin E Pszepczynska-Guigne JC Roujeau J Revuz 2006 Performance of the SCORTEN during the first 5 days of hospitalization to predict the prognosis of epidermal necrolyse J Invest Dermatol 126 272 276 10.1038/sj.jid.5700068 16374461 (Pubitemid 43323160)
15. SS Vaishampayan AL Das R Verma 2008 SCORTEN: does it need modification? Indian J Dermatol Venereol Leprol 74 35 37 10.4103/0378-6323.38405 18187821
16. JS Hague JM Goulding TM Long BC Gee 2007 Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN Br J Dermatol 157 1294 1296 10.1111/j.1365-2133.2007.08222.x 17916192 (Pubitemid 350115695)
17. GK Patel AY Finlay 2003 Staphylococcal scalded skin syndrome: diagnosis and management Am J Clin Dermatol 4 165 175 10.2165/00128071-200304030-00003 12627992 (Pubitemid 36390473)
18. M Mockenhaupt C Viboud A Dunant L Naldi S Halevy JN Bouwes Bavinck A Sidoroff J Schneck JC Roujeau A Flahault 2008 Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study J Invest Dermatol 128 35 44 10.1038/sj.jid.5701033 17805350 (Pubitemid 350249390)
19. S Halevy PD Ghislain M Mockenhaupt JP Fagot JN Bouwes Bavinck A Sidoroff L Naldi A Dunant C Viboud JC Roujeau EuroSCAR Study Group 2008 Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel J Am Acad Dermatol 58 25 32 10.1016/j.jaad.2007.08.036 17919772 (Pubitemid 350298142)
20. N Levi S Bastuji-Garin M Mockenhaupt JC Roujeau A Flahault JP Kelly E Martin DW Kaufman P Maison 2009 Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis Pediatrics 123 e297 e304 10.1542/peds.2008-1923 19153164
21. Chung WH, Hung SI, Yang JY, Su SC, Huang SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, Yang CH, Lu CF, Wu JY, Liao YD, Chen YT (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343-1350
22. P Paquet GE Pierard 2007 Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review) Int J Mol Med 19 3 10 17143541
23. B Khalili SL Bahna 2006 Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis Ann Allergy Asthma Immunol 97 272 280 17042130
24. R Abe 2008 Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases J Dermatol Sci 52 151 159 10.1016/j.jdermsci.2008.06.003 18657400
25. WH Chung SI Hung YT Chen 2007 Human leukocyte antigens and drug hypersensitivity Curr Opin Allergy Clin Immunol 7 317 323 10.1097/ACI. 0b013e3282370c5f 17620823 (Pubitemid 47052019)
26. C Lonjou N Borot P Sekula N Ledger L Thomas S Halevy L Naldi JN Bouwes Bavinck A Sidoroff C de Toma M Schumacher JC Roujeau A Hovnanian M Mockenhaupt RegiSCAR study Group 2008 A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs Pharmacogenet Genomics 18 99 107 10.1097/FPC.0b013e3282f3ef9c 18192896
27. S Goyal P Gupta CM Ryanl M Kazlas N Noviski RL Sheridan 2009 Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations J Burn Care Res 30 437 439 10.1097/BCR.0b013e3181a28c82 19349890
28. LC Hughey 2007 Fever and erythema in the emergency room Semin Cutan Med Surg 26 133 138 10.1016/j.sder.2007.09.007 18070679 (Pubitemid 350216504)
29. E McGee A Munster 1998 Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center Plast Reconstr Surg 102 118
30. E Rivers B Nguyen S Havstad J Ressler A Muzzin B Knoblich E Peterson M Tomlanovich Early Goal-Directed Therapy Collaborative Study Group 2001 Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 1368 1377 10.1056/NEJMoa010307 11794169 (Pubitemid 34940725)
31. RP Dellinger MM Levy JM Carlet J Bion MM Parker R Jaeschke K Reinhart DC Angus C Brun-Buisson R Beale T Calandra JF Dhainaut H Gerlach M Harvey JJ Marini J Marshall M Ranieri G Ramsay J Sevransky BT Thompson S Townsend JS Vender JL Zimmerman JL Vincent 2008 Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 17 60 10.1007/s00134-007-0934-2 18058085
32. W Schummer 2009 Central venous pressure validity, informative value and correct measurement Anaesthesist 58 499 505 10.1007/s00101-009-1529-9 19458975
33. J Brierley JA Carcillo K Choong T Cornell A Decaen A Deymann A Doctor A Davis J Duff MA Dugas A Duncan B Evans J Feldman K Felmet G Fisher L Frankel H Jeffries B Greenwald J Gutierrez M Hall YY Han J Hanson J Hazelzet L Hernan J Kiff N Kissoon A Kon J Irazuzta J Lin A Lorts M Mariscalco R Mehta S Nadel T Nguyen C Nicholson M Peters R Okhuysen-Cawley T Poulton M Relves A Rodriguez R Rozenfeld E Schnitzler T Shanley S Kache P Skippen A Torres B von Dessauer J Weingarten T Yeh A Zaritsky B Stojadinovic J Zimmerman A Zuckerberg 2009 Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine Crit Care Med 37 666 688 10.1097/CCM.0b013e31819323c6 19325359
34. BN Pruitt Jr 1987 Burn treatment for the unburned JAMA 257 2207 2208 10.1001/jama.257.16.2207 3560404
35. J Oda K Yamashita T Inoue N Harunari Y Ode K Mega Y Aoki M Noborio M Ueyama 2006 Resuscitation fluid volume and abdominal compartment syndrome in patients with major burns Burns 32 151 154 10.1016/j.burns.2005.08.011 16451820 (Pubitemid 43197649)
36. EL Daugherty Hongyan Liang D Taichman J Hansen-Flaschen BD Fuchs 2007 Abdominal compartment syndrome is common in medical intensive care unit patients receiving large-volume resuscitation J Intensive Care Med 22 294 299 10.1177/0885066607305247 17895487 (Pubitemid 350195231)
37. W Mullens Z Abrahams GS Francis DO Taylor RC Starling WH Tang 2008 Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure J Card Fail 14 508 514 10.1016/j.cardfail.2008.02.010 18672199 (Pubitemid 352040863)
38. W Mullens Z Abrahams GS Francis HN Skouri RC Starling JB Young DO Taylor WH Tang 2008 Sodium nitroprusside for advanced low-output heart failure J Am Coll Cardiol 52 200 207 10.1016/j.jacc.2008.02.083 18617068 (Pubitemid 351915785)
39. JC Roujeau O Chosidow P Saiag JC Guillauma 1990 Toxic epidermal necrolysis (Lyell syndrome) J Am Acad Dermatol 23 1039 1058 10.1016/0190- 9622(90)70333-D 2273103
40. M Gandhi A Kowal-Vern G An M Hanumadass 2008 Blister fluid composition in a pediatric patient with toxic epidermal necrolysis J Burn Care Res 29 671 675 10.1097/BCR.0b013e31817db8c8 18535474
41. M Lehnhardt HJ Jafari D Druecke L Steinstraesser HU Steinau W Klatte R Schwake HH Homann 2005 A qualitative and quantitative analysis of protein loss in human burn wounds Burns 31 159 167 10.1016/j.burns.2004.08.015 15683686 (Pubitemid 40430870)
42. J Boldt M Papsdorf 2008 Fluid management in burn patients: results from a European survey-more questions than answers Burns 34 323 328 10.1016/j.burns.2007.09.005
43. B Venkatesh J Gough DR Ralston M Muller S Pegg 2004 Protein losing enteropathy in critically ill adult patients with burns: a preliminary report Intensive Care Med 30 162 166 10.1007/s00134-003-2050-2 14634725 (Pubitemid 38147125)
44. P Perel I Roberts 2007 Colloids versus crystalloids for fluid resuscitation in critically ill patients Cochrane Database Syst Rev 17 CD000567
45. MJ Spirt 2004 Stress-related mucosal disease: risk factors and prophylactic therapy Clin Ther 26 197 213 10.1016/S0149-2918(04)90019-7 15038943 (Pubitemid 38339012)
46. J Kvasnicka J Rezac J Svejda H Duchkova F Kaze P Zalud J Richter 1979 Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell's syndrome) Br J Dermatol 100 551 558 10.1111/j.1365-2133. 1979.tb05580.x 444427
47. P Pottier JB Hardouin S Lejeune P Jolliet B Gillet B Planchon 2009 Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies Thromb Res 124 468 476 10.1016/j.thromres.2009.05.006 19481781
48. J Ballard L Edelman J Saffle R Sheridan R Kagan D Bracco L Cancio B Cairns R Baker B Fillari L Wibbenmeyer D Voight T Palmieri D Greenhalgh N Kemalyan D Caruso Multicenter Trials Group American Burn Association 2008 Positive fungal cultures in burn patients: a multicenter review J Burn Care Res 29 213 221 18182925
49. PH Halebian VJ Corder MR Madden JL Finklestein GT Shires 1986 Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids Ann Surg 204 503 512 10.1097/00000658-198611000-00001 3767483
50. J Schneck JP Fagot P Sekula B Sassolas JC Roujeau M Mockenhaupt 2008 Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study J Am Acad Dermatol 58 33 40 10.1016/j.jaad.2007.08. 039 17919775 (Pubitemid 350298143)
51. F Guibal S Bastuji-Garin O Chosidow P Saiag J Revuz JC Roujeau 1995 Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy Arch Dermatol 131 669 672 10.1001/archderm.131.6.669 7778917
52. SL Bahna B Khalili 2007 New concepts in the management of adverse drug reactions Allergy Asthma Proc 28 517 524 10.2500/aap2007.28.3030 18034968
53. AP Fernandez FA Kerdel 2007 The use of i.v. IG therapy in dermatology Dermatol Ther 20 288 305 10.1111/j.1529-8019.2007.00142.x 17970894 (Pubitemid 350029317)
54. N Bachot J Revuz JC Roujeau 2003 Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression Arch Dermatol 139 33 36 10.1001/archderm.139.1.33 12533161 (Pubitemid 36091571)
55. N Mittmann B Chan S Knowles L Cosentino N Shear 2006 Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome Am J Clin Dermatol 7 359 368 10.2165/00128071- 200607060-00004 17173470 (Pubitemid 46998570)
56. O Faye JC Roujeau 2005 Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date Drugs 65 2085 2090 10.2165/00003495-200565150-00002 16225365 (Pubitemid 41475790)
57. IS Whitaker S Prowse TS Potokar 2008 A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon Ann Plast Surg 60 333 337 10.1097/SAP.0b013e31806bf446 18443516
58. P Boorboor PM Vogt FG Bechara Q Alkandari M Aust A Gohritz M Spies 2008 Toxic epidermal necrolysis: use of Biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients Burns 34 487 492 10.1016/j.burns.2007.06.008 17919820
59. RL Dalli R Kumar P Kennedy P Maitz S Lee R Johnson 2007 Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management ANZ J Surg 77 671 676 10.1111/j.1445-2197.2007.04184.x 17635282 (Pubitemid 47063357)
60. DW Ryan 1995 The fluidised bed Intensive Care Med 21 270 276 10.1007/BF01701488 7790620
61. CT Hsiao LJ Lin CJ Shiao KY Hsiao IC Chen 2008 Hemorrhagic bullae are not only skin deep Am J Emerg Med 26 316 319 10.1016/j.ajem.2007.07.014 18358943
62. F Lebargy P Wolkenstein M Gisselbrecht F Lange J Fleury-Feith C Delclaux E Roupie J Revuz JC Roujeau 1997 Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study Intensive Care Med 23 1237 1244 10.1007/s001340050492 9470079 (Pubitemid 28017789)
63. R Jäckel M Fuchs T Raff B Wiedemann 2002 Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report Anaesthesist 51 815 819 10.1007/s00101-002-0404-8 12395172 (Pubitemid 35333022)
64. JD Fine LB Johnson M Weiner C Suchindran 2007 Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry Laryngoscope 117 1652 1660 10.1097/MLG.0b013e318093ed8e 17762793 (Pubitemid 47357399)
65. JP Windfuhr G Schloendorff D Baburi B Kremer 2008 Life-threatening posttonsillectomy hemorrhage Laryngoscope 118 1389 1394 10.1097/MLG. 0b013e3181734f7e 18496156
66. S Riazi K Karkouti J Heggie 2006 Case report: management of life-threatening oropharyngeal bleeding with recombinant factor VIIa Can J Anaesth 53 881 884 10.1007/BF03022830 16960265
67. E Kluger 1998 Fatal outcome in allopurinol hypersensitivity syndrome Ugeskr Laeger 160 1179 1180 9492630
68. A Garza AJ Waldman J Mamel 2005 A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization Gastrointest Endosc 62 638 642 10.1016/j.gie.2005.06.034 16185990 (Pubitemid 41383797)
69. V Krejci LB Hiltebrand GH Sigurdsson 2006 Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis Crit Care Med 34 1456 1463 10.1097/01.CCM. 0000215834.48023.57 16557162 (Pubitemid 43754570)
70. V Lamblin R Favory M Boulo D Mathieu 2006 Microcirculatory alterations induced by sedation in intensive care patients. Effects of midazolam alone and in association with sufentanil Crit Care 10 R176 10.1186/cc5128 17173680 (Pubitemid 46211018)
71. DG Gregory 2008 The ophthalmologic management of acute Stevens-Johnson syndrome Ocul Surf 6 87 95 18418506
72. J Lasudry 2007 The pathology of ocular syndromes caused by toxicity Bull Soc Belge Ophtalmol 304 155 178 17718241
73. YS Chang FC Huang SH Tseng CK Hsu CL HO HM Sheu 2007 Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management Cornea 26 123 129 10.1097/ICO. 0b013e31802eb264 17251797 (Pubitemid 46168276)
74. I Garcia-Doval L LeCleach H Bocquet XL Otero JC Roujeau 2000 Toxic epidermal necrolysis and Stevens-Johnson syndrome. Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 136 323 327 10.1001/archderm.136.3.323 10724193
75. RS Stern 2000 Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome Arch Dermatol 136 410 10.1001/archderm.136.3.410 10724207
76. M Mockenhaupt 2009 Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy J Dtsch Dermatol Ges 7 142 163 19371237
77. S Poloczek C Madler 2000 Transport of intensive care patients Anaesthesist 49 480 491 10.1007/s001010070122 10883368 (Pubitemid 30346273)
78. J Warren RE Fromm Jr RA Orr LC Rotello HM Horst American College of Critical Care Medicine 2004 Guidelines for the inter- and intrahospital transport of critically ill patients Crit Care Med 32 256 262 10.1097/01.CCM.0000104917.39204.0A 14707589
79. K Bork 2005 Pruritus precipitated by hydroxyethyl starch: a review Br J Dermatol 152 3 12 10.1111/j.1365-2133.2004.06272.x 15656795
80. NJ Holland GS Sandhu K Ghufoor A Frosh 2001 The Foley catheter in the management of epistaxis Int J Clin Pract 55 14 15 11219312
81. D Danzl 2002 Hypothermia Semin Respir Crit Care Med 23 57 68 10.1055/s-2002-20589 16088598